Join a webinar with OxSonics!

The event will feature a 20-minute presentation showcasing the Company and recent developments, as well as touching on the measures being taken to mitigate the effects of the COVID-19 pandemic. This will be followed by a 10-minute Q&A session with CEO, Colin Story and Finance Director, Chris Hill.

OxSonics was spun out from the Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory at the University of Oxford in 2014 to develop ground-breaking ultrasound technology that uses proprietary Sono-Sensitive Particles (SSPs) to increase the tumour penetration of cancer drugs. The event will represent the launch of an OTIF single stock silo contributing to OxSonics’s Series B fundraising round which will close in June 2020

The webinar will be held via Zoom and further details can be found in the invitation which is accessible here.

The Company’s overview is available upon request.

We hope you can join us and would be grateful if you could RSVP using the registration link here.

If you have any queries please contact Helen at helen@oxfordinvestmentconsultants.com.

Important notice: This is event is being held for information purposes only. Reliance on the information in this event communication and disclosed during the event itself, for the purpose of engaging in any investment activity, may expose an individual to a risk of losing all of the funds invested. Neither this communication or the information disclosed during the event constitute, or should be considered as, an offer to buy or sell or solicitation of an offer to buy or sell any security or share. The information contained in this communication and that disclosed during the event is NOT intended for retail investors. Upon RSVP’ing to the event you will be requested to confirm that you are one of either: A High Net Worth Individual or A Sophisticated Investor. Details of what is required to qualify as a High Net Worth Individual and a Sophisticated Investor can be viewed in detail here.